Lavier

Lavier was founded in 2018 and undertaken a Corporate Restructuring in early Jan 2020.

With the company’s new vision, we strive to become one of the leading Anti-Aging Solution Provider in Asia that equip with R&D laboratory, manufacturing facility and marketing arm.

According to Zion Market research, the global Anti-Aging market is growing at a CAGR of 7.5% during 2016 and 2021, it is expected to exceed US$271 billion by 2024 in the given forecast period.

A comprehensive Asian Development Bank (ADB) report also found that rapidly shifting demographics, particularly declining birth rates and increasing life expectancies, will increasingly shape the economic direction of developing countries in Asia. The favorable demographics that have driven high economic growth in the region are likely to reverse. “Asia’s population is aging quickly,” said Juzhong Zhuang, ADB’s Deputy Chief Economist.

By 2030, 60 percent of people 65 and older will call Asia home. Japan will become the world’s first “ultra-aged” nation with more than 28 percent of its population 65 and older. Hong Kong, Taiwan, and South Korea, which is aging faster than any other OECD country, will be “super-aged” with more than 21 percent above 65 soon.

In view of all these, apart from delivering high-quality and clinically effective products, we also continue our mission to promote and enhance social awareness of anti-aging to the society.

We believe with the help of our innovative OMO platform and incubation system, we are able to create a unique anti-aging ecology system that is shared across Asia.